ACHILLES THERAPEUTICS PL-ADR (ACHL)
US00449L1026 - ADR
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 86.05M | 131.54M | 173.30M | 266.30M | 177.80M | |||
| Receivables | 637.00K | 793.00K | 800.00K | 700.00K | 1.10M | |||
| Other Current Assets | 24.94M | 13.30M | 22.50M | 17.80M | 8.90M | |||
| Total Current Assets | 111.63M | 145.63M | 196.60M | 284.70M | 187.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.23M | 13.54M | 20.50M | 28.80M | 28.10M | |||
| Other Non-Current Assets | 1.82M | 2.28M | 3.30M | 3.60M | 3.00M | |||
| Total Non-Current Assets | 11.05M | 15.82M | 23.80M | 32.40M | 31.10M | |||
| TOTAL ASSETS | 122.68M | 161.46M | 220.40M | 317.10M | 218.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 12.98M | 10.52M | 11.30M | 14.10M | 8.90M | |||
| Accounts Payable | 4.25M | 5.63M | 5.20M | 3.70M | 6.30M | |||
| Other Current Liabilities | 1.24M | 850.00K | 1.50M | 1.30M | 1.40M | |||
| Total Current Liabilities | 18.47M | 17.00M | 18.00M | 19.10M | 16.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.07M | 2.09M | 5.30M | 8.50M | 12.90M | |||
| Total Non-Current Liabilities | 1.07M | 2.09M | 5.30M | 8.50M | 12.90M | |||
| TOTAL LIABILITIES | 19.54M | 19.09M | 23.30M | 27.60M | 29.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -308.20M | -259.95M | -190.30M | -119.10M | -58.00M | |||
| Additional Paid In Capital | 419.10M | 415.21M | 408.80M | 401.80M | 234.90M | |||
| Common Shares | 182.00K | 182.00K | 200.00K | 200.00K | 100.00K | |||
| Other Shareholders' Equity | -7.94M | -13.07M | -21.70M | 6.60M | 12.30M | |||
| Shares Outstanding | 43.42M | 43.40M | 43.20M | 42.89M | 42.89M | |||
| Tangible Book Value per Share | 2.51 | 3.47 | 4.82 | 7.13 | 4.66 | |||
| Total Shareholders' Equity | 103.14M | 142.37M | 197.00M | 289.50M | 189.40M | |||
| TOTAL LIABILITIES AND EQUITY | 122.68M | 161.46M | 220.40M | 317.10M | 218.90M | |||
| Statistics | ||||||||
| Current Ratio | 6.04 | 8.57 | 10.92 | 14.91 | 11.31 | |||
| Return On Assets (ROA) | -54.52% | -43.15% | -32.30% | -19.27% | -15.17% | |||
| Return On Equity (ROE) | -64.84% | -48.93% | -36.13% | -21.11% | -17.53% | |||
All data in USD , ROIC based on taxRate of 0.21